Kerry A. Wentworth
2012
In 2012, Kerry A. Wentworth earned a total compensation of $824.4K as Vice President, Clinical, Regulatory and Quality at Agenus, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $40,778 |
|---|---|
| Option Awards | $325,691 |
| Salary | $260,762 |
| Stock Awards | $189,197 |
| Other | $7,938 |
| Total | $824,366 |
Wentworth received $325.7K in option awards, accounting for 40% of the total pay in 2012.
Wentworth also received $40.8K in non-equity incentive plan, $260.8K in salary, $189.2K in stock awards and $7.9K in other compensation.
Rankings
In 2012, Kerry A. Wentworth's compensation ranked 6,897th out of 11,487 executives tracked by ExecPay. In other words, Wentworth earned more than 40.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,897 out of 11,487 | 40th |
Division Manufacturing | 2,474 out of 4,253 | 42nd |
Major group Chemicals And Allied Products | 628 out of 1,198 | 48th |
Industry group Drugs | 430 out of 920 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 71 out of 160 | 56th |
Source: SEC filing on March 10, 2014.
Wentworth's colleagues
We found four more compensation records of executives who worked with Kerry A. Wentworth at Agenus in 2012.